Therapeutic Areas
Over 25 years of Peptide Drug Research and Discovery
Our Brands
Over 2,000,000 scientist hours into new peptide drug development, ISSAR has touched 100000 plus lives
Development Pipeline
Solving the unmet healthcare needs using novel peptide technology
Novoskin®
Vitiligo - Topical
Xylentra®
Wound care - Topical
IS -107
Solid tumors - Injectable
IS - 217
Soriacare®
Psoriasis - Injectable
Topical
ISSAR'S Pre-Clinical
Pipeline
INDIA
INDIA
US FDA
INDIA
US FDA
IBD (Injectable)
Sepsis (Injectable)
Rheumatoid Arthritis
Atopic Dermatitis